PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Med Genet. 1987 June; 24(6): 344–347.
PMCID: PMC1050099

Prenatal diagnosis of congenital adrenal hyperplasia: reliability of amniotic fluid steroid analysis.

Abstract

The concentration of 170H-progesterone was measured in amniotic fluid samples collected from 55 mothers who had previously had a child with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In eight pregnancies the levels of 170H-progesterone were raised; the parents elected to terminate in four and examinations of the fetus confirmed the diagnosis of congenital adrenal hyperplasia. In each case, the affected sib was a salt loser. The remaining four affected pregnancies proceeded to term and each infant had salt losing 21-hydroxylase deficiency. All 47 infants predicted to be unaffected were normal at birth. However, an increased plasma concentration of 170H-progesterone was documented in a male non-salt loser at three months of age. Prenatal diagnosis of congenital adrenal hyperplasia by amniotic fluid steroid analysis is reliable only for the salt losing variant of 21-hydroxylase deficiency. Of the affected sibs in this study, 20% died during infancy in a salt losing crisis. This simple and rapid prenatal test is sufficiently reliable to predict the group of infants most at risk in early infancy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (733K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hughes IA. Congenital and acquired disorders of the adrenal cortex. Clin Endocrinol Metab. 1982 Mar;11(1):89–125. [PubMed]
  • Youssefnejadian E, David R. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone. Clin Endocrinol (Oxf) 1975 Jul;4(4):451–454. [PubMed]
  • Hughes IA, Riad-Fahmy D, Griffiths K. Plasma 17OH-progesterone concentrations in newborn infants. Arch Dis Child. 1979 May;54(5):347–349. [PMC free article] [PubMed]
  • Serón-Ferré M, Jaffe RB. The fetal adrenal gland. Annu Rev Physiol. 1981;43:141–162. [PubMed]
  • Nagamani M, McDonough PG, Ellegood JO, Mahesh VB. Maternal and amniotic fluid 17 alpha-hydroxyprogesterone levels during pregnancy: diagnosis of congenital adrenal hyperplasia in utero. Am J Obstet Gynecol. 1978 Apr 1;130(7):791–794. [PubMed]
  • New MI. Clinical and endocrinological aspects of 21-hydroxylase deficiency. Ann N Y Acad Sci. 1985;458:1–27. [PubMed]
  • Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. Ann N Y Acad Sci. 1985;458:111–129. [PubMed]
  • Dyas J, Read GF, Guha-Maulik T, Hughes IA, Riad-Fahmy D. A rapid assay for 17 alpha OH-progesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum. Ann Clin Biochem. 1984 Sep;21(Pt 5):417–424. [PubMed]
  • Bowen DM, White P, Spillane JA, Goodhardt MJ, Curzon G, Iwangoff P, Meier-Ruge W, Davison AN. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 1979 Jan 6;1(8106):11–14. [PubMed]
  • Forest MG, Bétuel H, Couillin P, Boué A. Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency by steroid analysis in the amniotic fluid of mid-pregnancy: comparison with HLA typing in 17 pregnancies at risk for CAH. Prenat Diagn. 1981 Jul;1(3):197–207. [PubMed]
  • New MI, Speiser PW. Genetics of adrenal steroid 21-hydroxylase deficiency. Endocr Rev. 1986 Aug;7(3):331–349. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group